Retrieved from Popson, M
M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O
Those who received oral semaglutide as the first- or second-choice therapy were defined as the first- or second-choice therapy group, whereas those who received it as the third or subsequent choice were classified as the third- or subsequent-choice therapy group
Your attorney can provide more specific timelines based on the current status of the litigation
Based on the STEP 1 clinical trial, patients lost approximately 2% of body weight per month for the first six months, slowing to about 1% per month thereafter, reaching an average of ~1516% total body weight loss by week 68
For most people, yes